TY  - CHAP
AU  - Muhammad Shafique
AU  - Muhammad Asif Zahoor
AU  - Muhammad Imran Arshad
AU  - Bilal Aslam
AU  - Abu Baker Siddique
AU  - Muhammad Hidayat Rasool
AU  - Muhammad Usman Qamar
AU  - Muhammad Usman
ED  - Bernhard Resch
Y1  - 2019-08-01
PY  - 2019
T1  - Hurdles in Vaccine Development against Respiratory Syncytial Virus
N2  - Respiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine.
BT  - The Burden of Respiratory Syncytial Virus Infection in the Young
SP  - Ch. 5
UR  - https://doi.org/10.5772/intechopen.87126
DO  - 10.5772/intechopen.87126
SN  - 978-1-78984-643-0
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -